Clinical drug diversion is a critical issue in pharmacies and health systems nationwide. Healthcare workers who steal or misuse controlled substances (CS) cause direct harm to patients and put their employers at risk for financial penalties and sanctions.
Presented by Dwight de Vera, GM Healthcare Intelligence at Inmar, and Nick Culbertson, Co-Founder and CEO at Protenus, this webinar explores the following: